Publications database

In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing...

These are the EMCDDA's final annual accounts for the financial year 2019.

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

Over the past quarter of a century, the EMCDDA has expanded its monitoring capability to keep pace with revolutionary changes in the extent and nature of the drugs problem and in the...

Follow the timeline and take a walk through some of the key moments in the EMCDDA's 25 years of international cooperation.

Take a journey through some of the key moments in the EMCDDA’s first quarter of a century by following the timeline and checking our main milestones.

The Programming Document 2020-22 translates the long-term priorities defined by the EMCDDA Strategy 2025 into short-term operational priorities. The year 2020 marks the end of the first strategic roadmap and the beginning...

These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council...

This information brochure has been produced by the EMCDDA to provide answers to the most commonly asked questions on the Reitox network of national focal points and more broadly on national drugs...

On the basis of an external evaluation of the EU drugs strategy 2005-12, on 7 December 2012 the Justice and Home Affairs Council of the European Union endorsed a new EU drugs...